Literature DB >> 11513564

T-cell immunity in the induction and maintenance of a tumour dormant state.

V Schirrmacher1.   

Abstract

We conclude from animal tumour model studies that T cell immunity can play an essential role in the induction and maintenance of tumour dormancy. Evidence was found in tumour dormancy situations for active control of proliferating tumour cells by CD8 memory T cells leading to a long-term balance in the bone marrow between low numbers of tumour cells and immunological memory. In breast cancer patients, too, the bone marrow may represent a privileged compartment for tumour dormancy and immunological memory. Upon restimulation with tumour antigen pulsed autologous dendritic cells, bone marrow-derived memory T cells from cancer patients could be shown to exist and to become activated into potent anti-tumour effector cells. Copyright 2001 Academic Press.

Entities:  

Mesh:

Year:  2001        PMID: 11513564     DOI: 10.1006/scbi.2001.0384

Source DB:  PubMed          Journal:  Semin Cancer Biol        ISSN: 1044-579X            Impact factor:   15.707


  8 in total

Review 1.  Metronomic chemotherapy: new rationale for new directions.

Authors:  Eddy Pasquier; Maria Kavallaris; Nicolas André
Journal:  Nat Rev Clin Oncol       Date:  2010-06-08       Impact factor: 66.675

Review 2.  T cell memory, anergy and immunotherapy in breast cancer.

Authors:  Volker Schirrmacher; Markus Feuerer; Philipp Beckhove; Thorsten Ahlert; Viktor Umansky
Journal:  J Mammary Gland Biol Neoplasia       Date:  2002-04       Impact factor: 2.673

3.  Intraoperative subcutaneous or intrasplenic vaccination with modified autologous tumor cells leads to enhanced survival in a mouse tumor model.

Authors:  Arne Dietrich; Christoph Stockmar; Gabriela Aust; Susan Endesfelder; Anke Guetz; Ulrich Sack; Manfred Schoenfelder; Johann Hauss
Journal:  J Cancer Res Clin Oncol       Date:  2006-01-04       Impact factor: 4.553

4.  Detection of circulating tumor cells and tumor stem cells in patients with breast cancer by using flow cytometry: a valuable tool for diagnosis and prognosis evaluation.

Authors:  Ningfang Wang; Lan Shi; Huiyu Li; Yanjie Hu; Wen Du; Wei Liu; Jin'e Zheng; Shiang Huang; Xincai Qu
Journal:  Tumour Biol       Date:  2012-01-13

5.  The impact of intraoperative vaccination with IL-12 modified autologous tumor cells in the Lewis lung carcinoma mouse model.

Authors:  Arne Dietrich; Christoph Stockmar; Susan Endesfelder; Anke Guetz; Gabriela Aust
Journal:  J Cancer Res Clin Oncol       Date:  2012-02-10       Impact factor: 4.553

6.  CD28 expression in sentinel node biopsies from breast cancer patients in comparison with CD3-zeta chain expression.

Authors:  Jana M Schüle; Leif Bergkvist; Leif Håkansson; Bertil Gustafsson; Annika Håkansson
Journal:  J Transl Med       Date:  2004-12-21       Impact factor: 5.531

Review 7.  [Metronomic Chemotherapy--A New Path to Treat Advanced Non-small Cell Lung Cancer].

Authors:  Shuang Zhang; Jingjing Liu; Ying Cheng
Journal:  Zhongguo Fei Ai Za Zhi       Date:  2015-04

8.  Can pharmacological receptor tyrosine kinase inhibitors sensitize poor outcome breast tumors to immune-based therapies?

Authors:  Josie Ursini-Siegel
Journal:  Front Oncol       Date:  2013-02-13       Impact factor: 6.244

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.